Item 5.01 Changes in Control of Registrant.
On January 17, 2022, as a result of a private transactions, 75,674,200 shares of
common stock, $0.001 par value per share (the "Shares") of Green Vision
Biotechnology Corp., a Nevada corporation (the "Company"), were transferred from
Leung Kwong Tak to Well Supreme International Limited (the "Purchaser"), through
the sale of all of the issued and outstanding shares of common stock of Able
Lead Holdings Limited, the former holder of the Shares. William Ching Wan Lam is
the owner of the Purchaser. As a result, the Purchaser, and William Ching Wan
Lam, the Company's Chief Executive Officer and a Director, through his control
of the Purchaser became a holder of approximately 50.796% of the voting rights
of the issued and outstanding share capital of the Company on a fully-diluted
basis of the Company, and became the controlling shareholder. The consideration
paid for the Shares was $227,023. The source of the cash consideration for the
Shares was personal funds of the Purchaser.
There are no arrangements or understandings among both the former and new
control persons and their associates with respect to the election of directors
of the Company or other matters.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 SUMMARY OF STOCK PURCHASE AGREEMENT, dated December 2, 2021, by and
between Well Supreme International Limited and Leung Kwong Tak
2
© Edgar Online, source Glimpses
